Whole-Body 18F-FDG PET/CT Is Superior to CT as First-Line Diagnostic Imaging in Patients Referred with Serious Nonspecific Symptoms or Signs of Cancer: A Randomized Prospective Study of 200 Patients-Reference-Cited by-同舟云学术

Whole-Body 18F-FDG PET/CT Is Superior to CT as First-Line Diagnostic Imaging in Patients Referred with Serious Nonspecific Symptoms or Signs of Cancer: A Randomized Prospective Study of 200 Patients

Published:2017-01-12 Issue:7 Volume:58 Page:1058-1064
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Lebech Anne-Mette,Gaardsting Anne,Loft Annika,Graff Jesper,Markova Elena,Bertelsen Anne Kiil,Madsen Jan Lysgård,Andersen Kim Francis,Benzon Eric von,Helms Morten,Mathiesen Lars R.,David Kim P.,Kronborg Gitte,Kjaer Andreas

Publisher

Society of Nuclear Medicine

Subject

Radiology Nuclear Medicine and imaging

Reference27 articles.

1. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data

2. Organisation of diagnosing patients with unspecific cancer symptoms [in Danish];Fredberg;Ugeskr Laeger.,2011

3. Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5—a population-based study

4. Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)

5. Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advances of Copper-64 Based Radiopharmaceuticals in Nuclear Medicine;Advances in Dosimetry and New Trends in Radiopharmaceuticals;2024-01-05

2. Patients from general practice with non-specific cancer symptoms: a retrospective study of symptoms and imaging;BJGP Open;2023-08-21

3. Hyperpolarized Carbon-13 MRI in Breast Cancer;Diagnostics;2023-07-07

4. Surveillance Imaging with PET/CT and CT and/or MRI for Head and Neck Cancer and Mortality: A Population-based Study;Radiology;2023-04-01

5. Combined plasma C‐reactive protein, interleukin 6 and YKL ‐40 for detection of cancer and prognosis in patients with serious nonspecific symptoms and signs of cancer;Cancer Medicine;2022-11-28